...Vincenzo Fanelli; Giovanni Sanna; Angela Solinas A controlled trial of hepatitis B vaccination with recombinant antigen was undertaken in 18 hemodialysed end-stage renal failure (ESRD) patients (P) and 16 members of our staff (controls, C). In order to identify expected nonresponders (NR), we...

...Massimo Melappioni; Massimo Baldassari; Sergio Saldini; Romolo Radicioni; Nello Panichi Thymopentine is a synthetic immunomodulator that positively affects T-lymphocyte maturation, reproduction and differentiation. In elderly uremic patients nonresponders to hepatitis B vaccine, the administration...

.... Hepatitis B vaccine Intradermal inoculation Seroconversion Booster dose Nephron 1991:58:47-51 © 19VI S. Karger AG. Basel 0028 2766/91/0581 0047S2.75/0 Complete Seroconversion by Low-Dose Intradermal Injection of Recombinant Hepatitis B Vaccine in Hemodialysis Patients Keiji Ono', Seizaburo Kashiwagih...

... data have revealed that only 50% of HD patients given hepatitis B vaccine produce antibody as compared to 95% of normal individuals. However, more recent data has shown that a higher dose and more frequent HB vaccination increased the rate of seroconversion to 60–75% in chronic dialysis patients [ 2, 3...